April 17, 2007

Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment

Key Points

Key points are not available for this paper at this time.

Abstract

Relative to placebo, antidepressants are efficacious for pediatric MDD, OCD, and non-OCD anxiety disorders, although the effects are strongest in non-OCD anxiety disorders, intermediate in OCD, and more modest in MDD. Benefits of antidepressants appear to be much greater than risks from suicidal ideation/suicide attempt across indications, although comparison of benefit to risk varies as a function of indication, age, chronicity, and study conditions.

Bookmark

Cite This Study

Bridge et al. (Tue,) studied this question.

synapsesocial.com/papers/69d9764aa1d151c65f68439b https://doi.org/https://doi.org/10.1001/jama.297.15.1683

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1ECDEU Assessment Manual for Psychopharmacology1976 · 8,825 citations
2Venlafaxine in the treatment of children and adolescents with major depression.1997 · 147 citations
3The Risk for Early-Adulthood Anxiety and Depressive Disorders in Adolescents With Anxiety and Depressive Disorders1998 · 1,773 citations
4Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report2006 · 5,526 citations
5Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships1995 · 69 citations

Bookmark